Cargando…

Current challenges in peptide-based drug discovery

Detalles Bibliográficos
Autores principales:	Otvos, Laszlo, Wade, John D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126357/ https://www.ncbi.nlm.nih.gov/pubmed/25152873 http://dx.doi.org/10.3389/fchem.2014.00062

Ejemplares similares

Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development
por: Ostorhazi, Eszter, et al.
Publicado: (2018)

The Effect of Selective D- or N(α)-Methyl Arginine Substitution on the Activity of the Proline-Rich Antimicrobial Peptide, Chex1-Arg20
por: Li, Wenyi, et al.
Publicado: (2017)

Development of second generation peptides modulating cellular adiponectin receptor responses
por: Otvos, Laszlo, et al.
Publicado: (2014)

Challenges in natural product-based drug discovery assisted with in silico-based methods
por: Simoben, Conrad V., et al.
Publicado: (2023)

Racing on the Wrong Track
por: Otvos, Laszlo
Publicado: (2017)

Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs
por: Brakel, Alexandra, et al.
Publicado: (2019)

Editorial: Current approaches in infectious disease drug discovery
por: Silva-Jr, Floriano P., et al.
Publicado: (2022)

Recent Advances Toward the Discovery of Drug-Like Peptides De novo
por: Goldflam, Michael, et al.
Publicado: (2015)

A focus on the discovery of potent and selective cyclic peptide scaffolds for drug development
por: Saunders, George J., et al.
Publicado: (2022)

Current Landscape of Antiviral Drug Discovery
por: Blair, Wade, et al.
Publicado: (2016)

Fragment-based drug discovery: opportunities for organic synthesis
por: St. Denis, Jeffrey D., et al.
Publicado: (2020)

The Current Challenges for Drug Discovery in CNS Remyelination
por: Balestri, Sonia, et al.
Publicado: (2021)

Structure-guided design of CPPC-paired disulfide-rich peptide libraries for ligand and drug discovery
por: Wu, Yapei, et al.
Publicado: (2022)

Is it time for biocatalysis in fragment-based drug discovery?
por: Ramsden, Jeremy I., et al.
Publicado: (2020)

Levoglucosenone: Bio-Based Platform for Drug Discovery
por: Camp, Jason E., et al.
Publicado: (2022)

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo
por: Otvos Jr., Laszlo, et al.
Publicado: (2018)

Glycans in drug discovery
por: Valverde, Pablo, et al.
Publicado: (2019)

Mycobacterial drug discovery
por: Abrahams, Katherine A., et al.
Publicado: (2020)

Automated affinity selection for rapid discovery of peptide binders
por: Zhang, Genwei, et al.
Publicado: (2021)

Bioinformatics-guided discovery of biaryl-linked lasso peptides
por: Saad, Hamada, et al.
Publicado: (2023)

Metallodrugs are unique: opportunities and challenges of discovery and development
por: Anthony, Elizabeth J., et al.
Publicado: (2020)

Target-templated de novo design of macrocyclic d-/l-peptides: discovery of drug-like inhibitors of PD-1
por: Guardiola, Salvador, et al.
Publicado: (2021)

Discovery of reactive peptide inhibitors of human papillomavirus oncoprotein E6
por: Ye, Xiyun, et al.
Publicado: (2023)

Editorial: Antimicrobial and Anticancer Peptides
por: O'Brien-Simpson, Neil M., et al.
Publicado: (2018)

Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity
por: Brakel, Alexandra, et al.
Publicado: (2022)

Chemical Glycosylation and Its Application to Glucose Homeostasis-Regulating Peptides
por: Chandrashekar, Chaitra, et al.
Publicado: (2021)

Metabolomics in infectious diseases and drug discovery
por: Tounta, Vivian, et al.
Publicado: (2021)

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation
por: Alcaro, Stefano, et al.
Publicado: (2019)

Discovery of cell active macrocyclic peptides with on-target inhibition of KRAS signaling
por: Lim, Shuhui, et al.
Publicado: (2021)

Natural product drug discovery in the artificial intelligence era
por: Saldívar-González, F. I., et al.
Publicado: (2021)

Correction: Recent updates in the discovery and development of novel antimalarial drug candidates
por: Okombo, John, et al.
Publicado: (2018)

Editorial: In silico Methods for Drug Design and Discovery
por: Brogi, Simone, et al.
Publicado: (2020)

Editorial: Advances in green synthesis for drug discovery
por: Allais, Florent, et al.
Publicado: (2023)

Supramolecular Self-Assembled Peptide-Based Vaccines: Current State and Future Perspectives
por: Abdullah, Turdimuhammad, et al.
Publicado: (2020)

Peptide-based positron emission tomography probes: current strategies for synthesis and radiolabelling
por: Failla, Mariacristina, et al.
Publicado: (2023)

Drug discovery research in Ghana, challenges, current efforts, and the way forward
por: Amewu, Richard Kwamla, et al.
Publicado: (2022)

The pursuit of mechanism of action: uncovering drug complexity in TB drug discovery
por: Yuan, Tianao, et al.
Publicado: (2021)

In silico peptide-directed ligand design complements experimental peptide-directed binding for protein–protein interaction modulator discovery
por: Howell, Lesley Ann, et al.
Publicado: (2020)

Discovery and characterisation of an amidine-containing ribosomally-synthesised peptide that is widely distributed in nature
por: Russell, Alicia H., et al.
Publicado: (2021)

Design and development of a peptide-based adiponectin receptor agonist for cancer treatment
por: Otvos, Laszlo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cj10t2mrug5mjpsorkn9a1ksan